Kuala Lumpur - Delayed Quote MYR

IHH Healthcare Berhad (5225.KL)

6.88

+0.02

+(0.29%)

At close: 4:50:03 PM GMT+8

IHH Healthcare Bhd (XKLS:5225) Q3 2024 Earnings Call Highlights: Strong Revenue and EBITDA ...

IHH Healthcare Bhd (XKLS:5225) reports robust financial performance with significant growth across key markets, despite facing operational challenges.

GuruFocus.com 4 months ago

IHHHF
IHH reports highest ever quarterly revenue in Q1 2024, with double-digit growth across key metrics, on outstanding performance across all markets

KUALA LUMPUR, Malaysia and SINGAPORE, May 29, 2024 (GLOBE NEWSWIRE) -- Revenue at RM6.0 billion mark for the first timeOutstanding growth momentum: revenue up 16%, EBITDA up 19%Core profit or PATMI (ex EI) up 22%; Lower headline PATMI due to high base in previous period (Q1 2023) which included one-off gain from sale of non-core asset IMU “We carried strong growth momentum into Q1 2024, with quarterly revenue hitting the RM6.0 billion mark for the first time. This outstanding performance cut acr

GlobeNewswire 10 months ago

IHHHF
IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre

Mount Elizabeth Novena Proton Therapy Centre Opening From left to right:1. Sherrie Lim, Chief Executive Officer, Mount Elizabeth Novena Hospital2. Dr Peter Chow, Chief Executive Officer, IHH Healthcare Singapore3. Tan Sri Mohammed Azlan bin Hashim, Chairman, IHH Healthcare4. Dr Prem Kumar Nair, Group Chief Executive Officer, IHH Healthcare5. Tomo Nagahiro, Board member, IHH Healthcare6. Yong Yih Ming, Chief Operating Officer, IHH Healthcare Singapore Mount Elizabeth Novena Proton Therapy Centre

GlobeNewswire 11 months ago

IHHHF

Performance Overview

Return	5225.KL	FTSE Bursa Malaysia KLCI (^KLSE)
YTD	-4.99%	-8.27%
1-Year	+12.57%	-4.13%
3-Year	+12.17%	-5.96%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

IHH Healthcare Berhad (5225.KL)

IHH Healthcare Bhd (XKLS:5225) Q3 2024 Earnings Call Highlights: Strong Revenue and EBITDA ...

IHH reports highest ever quarterly revenue in Q1 2024, with double-digit growth across key metrics, on outstanding performance across all markets

IHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre

Performance Overview